相关实验视频

Updated: Jul 3, 2026

04:33

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Gustavo Vázquez¹, Verónica Grasso², Micaela Dines³

¹Department of Psychiatry, School of Medicine and Centre for Neuroscience Studies, Queen's University, Kingston, Ontario, Canada. International Consortium for Mood & Psychotic Disorder Research, McLean Hospital, Belmont, MA, EE. UU. . g.vazquez@queensu.ca.

Vertex (Buenos Aires, Argentina)

|January 13, 2026

概括

情绪障碍中的混合特征,结合躁狂和抑郁症状,是常见的,并且与严重的结果有关. 最近的研究强调了第二代抗精神病药物作为有效的治疗方法,与较旧的药物或抗抑郁药不同.

科学领域:

精神病学和心理健康精神病学和心理健康
情绪障碍研究研究情绪障碍
药理疗法药理疗法药理疗法

背景情况:

混合特征,混合躁狂/低躁狂和抑郁症状,是情绪障碍的一个核心方面.
诊断标准已经从限制性发展为维度方法,DSM-5引入了"混合特征"规范器,尽管局限性仍然存在.
最近的系统审查表明混合特征很普遍,影响18-35%的严重抑郁症,双相抑郁症和躁狂/躁狂发作.

研究的目的:

审查历史背景,流行病学发现和情绪障碍中混合特征的最新治疗证据.
突出诊断和治疗混合特征的临床意义和挑战.
强调需要改善诊断共识和长期控制试验的需要.

主要方法:

对历史诊断配方和关于混合特征的当前文献进行系统审查.
对不同情绪发作类型的流行病学数据的分析.
对药理学证据的评估,重点是最近对第二代抗精神病药物和其他治疗方法的试验.

主要成果:

混合特征与增加自杀风险,预后较差和治疗反应减少有关.
第二代抗精神病药物 (卢马特佩龙,卢拉西,齐普拉西,卡里普拉辛,奥兰扎/西) 显示出治疗混合特征的最强有力的证据.
已建立的情绪稳定剂 (,瓦尔酸盐,拉莫) 缺乏针对混合抑郁症发作的具体研究,抗抑郁药单一治疗的支持不足.

结论:

目前用于混合特征的诊断标准需要改进以提高灵敏度.
迫切需要更多的长期,受控的临床试验来指导混合特征的治疗策略.
优化混合特征的诊断和治疗对于改善情绪障碍患者的治疗结果至关重要.

相关概念视频

01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...

01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...

01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.

01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...